Evidence map›Paper›PMID 40699872›Full record

ArticleCurrent issues in molecular biology2025

Association of

Ioannis Kyriakidis, Iordanis Pelagiadis, Charalampos Pontikoglou, Helen A Papadaki, Eftichia Stiakaki

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ioannis KyriakidisDepartment of Pediatric Hematology-Oncology & Autologous Hematopoietic Stem Cell Transplantation Unit, University Hospital of Heraklion & Laboratory of Blood Diseases and Childhood Cancer Biology, School of Medicine, University of Crete, 71003 Heraklion, Greece.ORCID 0000-0002-8153-9643
Iordanis PelagiadisDepartment of Pediatric Hematology-Oncology & Autologous Hematopoietic Stem Cell Transplantation Unit, University Hospital of Heraklion & Laboratory of Blood Diseases and Childhood Cancer Biology, School of Medicine, University of Crete, 71003 Heraklion, Greece.ORCID 0000-0001-5737-3770
Charalampos PontikoglouDepartment of Hematology & Hemopoiesis Research Laboratory, School of Medicine, University of Crete and University Hospital of Heraklion, 71500 Heraklion, Greece.ORCID 0009-0002-7198-3887
Helen A PapadakiDepartment of Hematology & Hemopoiesis Research Laboratory, School of Medicine, University of Crete and University Hospital of Heraklion, 71500 Heraklion, Greece.ORCID 0000-0002-5146-9699
Eftichia StiakakiDepartment of Pediatric Hematology-Oncology & Autologous Hematopoietic Stem Cell Transplantation Unit, University Hospital of Heraklion & Laboratory of Blood Diseases and Childhood Cancer Biology, School of Medicine, University of Crete, 71003 Heraklion, Greece.ORCID 0000-0002-3343-5110

Funding

Special Account for Research Funds of the University of Crete 11515
6 · The paper itself

Abstract

MicroRNAs are key regulators of lymphoid differentiation, exhibiting a pivotal role in acute lymphoblastic leukemia (ALL) biology and prognosis. The initial steps of canonical miRNA biogenesis involve the microprocessor complex processing the primary miRNA transcripts into precursor miRNAs via Drosha.

Indexed as

acute lymphoblastic leukemiachildhooddisease susceptibilityDroshamicroprocessormicroRNApolymorphismprognosisrelapsesurvival

Identifiers

PMID40699872
PMCPMC12191901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.